Could a common diabetes pill prevent heart failure after a heart attack?
NCT ID NCT05764057
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether dapagliflozin, a drug already used for diabetes and heart failure, can help the heart heal better after a heart attack. About 450 adults who have had a heart attack and have weak heart pumping will receive either the drug or a placebo for 6 months. The goal is to see if the drug improves heart function and reduces harmful changes in heart structure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMI are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Cardiology AP-HP Hôpital européen Georges - Pompidou
RECRUITINGParis, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Insulin resistance may predict poor blood flow after heart attack stenting in diabetics
- Could dropping aspirin early after stent surgery be safer?
- Heart attack aftermath: which treatment causes less internal bleeding?
- Sound waves vs X-Rays: which guides heart stents better?
- Can a chinese herbal tablet help hearts heal after a heart attack?
- Heart surgery study questions routine use of ultrasound probe